Home > Publications Database > MRI phenotyping of underlying cerebral small vessel disease in mixed hemorrhage patients. |
Journal Article | DZNE-2022-00937 |
; ; ; ; ; ; ; ; ; ; ;
2020
Elsevier Science
Amsterdam [u.a.]
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.jns.2020.117173
Abstract: To investigate underlying cerebral small vessel disease (CSVD) in patients with mixed cerebral hemorrhages patterns and phenotype them according to the contribution of the two most common sporadic CSVD subtypes: cerebral amyloid angiopathy (CAA) vs. hypertensive arteriopathy (HA).Brain MRIs of patients with intracerebral hemorrhages (ICHs) and/or cerebral microbleeds (CMBs) were assessed for the full spectrum of CSVD markers using validated scales: ICHs, CMBs, cortical superficial siderosis (cSS), white matter hyperintensities, MRI-visible perivascular spaces (PVS). PVS predominance pattern was grouped as centrum-semiovale (CSO)-PVS predominance, basal-ganglia (BG)-PVS predominance, CSO-PVS and BG-PVS equality. Patients with mixed cerebral hemorrhages were classified into mixed CAA-pattern or mixed HA-pattern according to the existence of cSS and/or a CSO-PVS predominance pattern and comparisons were performed.We included 110 patients with CAA (strictly lobar ICHs/CMBs), 33 with HA (strictly deep ICHs/CMBs) and 97 with mixed lobar/deep ICHs/CMBs. Mixed patients were more similar to HA with respect to their MRI-CSVD markers, vascular risk profile and cerebrospinal fluid (CSF) measures. In the mixed patients, 33 (34%) had cSS, a CSO-PVS predominance pattern, or both, and were defined as mixed CAA-pattern cases. The mixed CAA-pattern patients were more alike CAA patients regarding their MRI-CSVD markers, CSF and genetic profile.Our findings suggest that the heterogeneous group of patients with mixed cerebral hemorrhages distribution can be further phenotyped according to the predominant underlying CSVD. cSS presence and a CSO-PVS predominance pattern could serve as strongly suggestive markers of a contribution from CAA among patients with mixed hemorrhages.
Keyword(s): Cerebral Amyloid Angiopathy (MeSH) ; Cerebral Hemorrhage: complications (MeSH) ; Cerebral Hemorrhage: diagnostic imaging (MeSH) ; Cerebral Small Vessel Diseases: complications (MeSH) ; Cerebral Small Vessel Diseases: diagnostic imaging (MeSH) ; Humans (MeSH) ; Magnetic Resonance Imaging (MeSH) ; Siderosis (MeSH) ; Cerebral amyloid angiopathy ; Cerebral small vessel diseases ; Cerebrospinal fluid ; Intracerebral hemorrhage ; MRI ; Vascular dementia